Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia
Dan Siskind, Andrea Baker, Urška Arnautovska, Nicola Warren, Anthony Russell, Veronica Eileen DeMonte, Sean Halstead, Ravi Iyer, Nicole Korman, Gemma McKeon, Sarah E. Medland, Stephen Parker, Terry Stedman, Mike Trott
Topics & Concepts
Schizoaffective disorderClozapineMedicinePopulationAntipsychoticPlaceboPaliperidoneSchizophrenia (object-oriented programming)SemaglutideWeight lossRisperidoneRandomized controlled trialInternal medicinePsychiatryPhysical therapyPsychosisObesityType 2 diabetesEndocrinologyDiabetes mellitusPathologyLiraglutideEnvironmental healthAlternative medicineDiabetes Treatment and ManagementSchizophrenia research and treatmentBariatric Surgery and Outcomes